- Main
Building a roadmap for developing combination therapies for Alzheimers disease.
- Perry, Daniel;
- Sperling, Reisa;
- Katz, Russell;
- Berry, Donald;
- Dilts, David;
- Hanna, Debra;
- Salloway, Stephen;
- Trojanowski, John;
- Bountra, Chas;
- Krams, Michael;
- Luthman, Johan;
- Potkin, Steven;
- Gribkoff, Val;
- Temple, Robert;
- Wang, Yaning;
- Carrillo, Maria;
- Stephenson, Diane;
- Snyder, Heather;
- Liu, Enchi;
- Ware, Tony;
- McKew, John;
- Fields, F;
- Bain, Lisa;
- Bens, Cynthia
- et al.
Published Web Location
https://doi.org/10.1586/14737175.2015.996551Abstract
Combination therapy has proven to be an effective strategy for treating many of the worlds most intractable diseases. A growing number of investigators in academia, industry, regulatory agencies, foundations and advocacy organizations are interested in pursuing a combination approach to treating Alzheimers disease. A meeting co-hosted by the Accelerate Cure/Treatments for Alzheimers Disease Coalition, the Critical Path Institute and the Alzheimers Association addressed challenges in designing clinical trials to test multiple treatments in combination and outlined a roadmap for making such trials a reality.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-